The Endometrial Ablation Market was valued at US$ 3.2 Billion in 2022 and is expected to grow with a CAGR of 7.3% from 2023 to 2033. Increasing awareness about women’s health and endometrial ablation, the surge in demand for minimally invasive procedures, and the rising prevalence of menorrhagia are some of the factors that are expected to drive the endometrial ablation market during the forecast period. The market accounted for an absolute dollar opportunity of nearly US$ 3.4 Billion from 2023 to 2033.
| Attribute | Details |
|---|---|
| Global Endometrial Ablation Market (2023) | US$ 3.4 Billion |
| Global Endometrial Ablation Market (2033) | US$ 6.8 Billion |
| Global Endometrial Ablation Market CAGR (2023 to 2033) | 7.3% |
| USA Endometrial Ablation Market CAGR (2023 to 2033) | 6.3% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Endometrial Ablation Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around a CAGR of 5.9%. Growing with an absolute dollar opportunity of US$ 3.4 Billion from 2023 to 2033, the market is projected to reach US$ 6.8 Billion by 2033.
With the advent of minimally invasive endometrial ablation treatments, the endometrium can be destroyed in a more expedient, outpatient setting. This operation is less dangerous and technically straightforward to carry out.
The International Federation of Gynaecology and Obstetrics estimates that between 3% and 30% of reproductive-aged women are affected by Abnormal Uterine Bleeding. Women's treatment plans have become the key focus of the general health industry in the modern world. Governments and private organizations around the world have placed women's health at the center of their wellbeing race.
In India, such as in many other locations, women are eligible for several tax benefits and exemptions under the provisions of several sections of the tax code. Women's healthcare initiatives may promote the effectiveness of treatment alternatives, which will boost the market.
Principal Consultant
Asia Pacific has high women population, which makes it a lucrative destination for endometrial ablation. Growing health infrastructure and awareness about new women’s healthcare technologies are further expected to swell the demand for endometrial ablation procedures in the region. Furthermore, the market is expected to develop due to an increase in the prevalence of menorrhagia. In the past years, the availability of ambulatory surgery centers and improved endometrial ablation devices in clinics are driving the regional demand.
The market in the USA is expected to reach a valuation of US$ 1.8 Billion by 2033. Between 2023 and 2033, the market is expected to expand by US$ 807.5 Million in absolute dollars.
The market in the United kingdom is expected to reach a valuation of US$ 319.8 Million by 2033. Growing with a CAGR of 8.4% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 176 Million.
In Japan, the market is expected to grow at a CAGR of 9.2% from 2023 to 2033, reaching around US$ 360 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 210 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around US$ 179 Million by 2033, growing at a CAGR of 8.5% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around US$ 99 Million.
The rising healthcare expenditure in India has increased growth prospects for the endometrial ablation market in the coming future. As the prevalence of cancer rises in India, so does the demand for various radiation devices and procedures. Furthermore, the government in India is focusing on expanding access to modern and sophisticated healthcare services as well as improving reimbursement coverage. For example, between 2019 and 2020, India's healthcare spending grew from 1.2% to 2.5% of GDP, as the government expanded healthcare spending.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market for radiation equipment has advanced significantly during the last decade. These advancements have contributed to the development of more effective, low-cost, and easy-to-use radiotherapy systems that offer enhanced and precise radiation doses, leading to increased tumor-targeting efficiency. With the move from 2D to 3D real-time imaging and planar radiotherapy, dose escalation with improved tumor control and enhanced conformance of radiation to the target growth in the near future, especially in mature markets where technologically advanced products are widely used.
Given these considerations, several market participants started to concentrate their efforts on the development, approval, and marketing of technologically upgraded products. In 2020, PMB, a part of the ALCEN Group, announced the launch of FLASHKNiFE, a FLASH radiation system specialized for clinical studies. In 2020, The Elekta Harmony linear accelerator was launched by Elekta, a system that can treat cancer with a 25% reduction in treatment time and a 30% reduction in footprint.
The goal of such technological improvements is to improve the functionality of radiation delivery systems while also broadening their application area. One of the primary factors driving the growth of the radiotherapy market is the increasing acceptance of these systems in various applications and settings.
In 2020, the hospital category accounted for a significant share due to an increase in the number of patients admitted to hospitals for gynecological issues. In addition, hospitals have advanced treatment devices, which helps in the segment's growth. Furthermore, hospitals experience a significantly higher influx of patients for gynecological treatments than other healthcare settings due to the convenience of handling any difficulties that may arise after surgical operations and the availability of a wide range of treatment alternatives in the facility.
The growth of the ablation technology market for surgical centers, hospitals, and ablation centers is fuelled by the rising prevalence of cancer, sports injuries, and heart problems.
The key players in the global endometrial ablation market are Medtronic, CooperSurgical Inc., Boston Scientific Corp., Ethicon, Inc., Olympus Corp., Richard Wolf GmbH, AngioDynamics, Hologic, Inc., and Minerva Surgical, Inc.
A few of the recent developments in the market are:
In 2023, the worldwide endometrial ablation market value could be around US$ 3.4 billion.
The overall market valuation is anticipated to reach nearly US$ 6.8 billion by 2033.
The United States leads the global market and could be valued at US$ 1.8 billion by 2033 end.
Japan at 9.2% CAGR may drive the regional Market through 2033.
Medtronic, CooperSurgical, and Boston Svientific are some top players in the market.
1. Executive Summary | Endometrial Ablation Market 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Future Market Insights Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and Foundation Data Points 4.1. Global Market (US$ Million) 4.2. Market Opportunity Assessment (US$ Million) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Global Market Growth 4.5.3. Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Analysis, 2018 to 2022 6.2. Current and Future Market Projections, 2023 to 2033 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022 7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Type Technique, 2018 to 2022 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type Technique, 2023 to 2033 8.3.1. Devices 8.3.1.1. Cryoablation 8.3.1.2. Radiofrequency Ablation 8.3.1.3. Hydrothermal Ablation 8.3.1.4. Thermal Balloon 8.3.1.5. Microwave Energy 8.3.2. Procedures 8.4. Market Attractiveness Analysis By Type Technique 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By End-User, 2018 to 2022 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-User, 2023 to 2033 9.3.1. Hospitals 9.3.2. Clinics 9.3.3. Ambulatory Surgery Centers 9.4. Market Attractiveness Analysis By End-User 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. Introduction 10.2. Historical Market Size (US$ Million) Analysis By Region, 2018 to 2022 10.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. Asia Pacific 10.3.5. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Introduction 11.2. Pricing Analysis 11.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 11.4.1. By Country 11.4.1.1. USA 11.4.1.2. Canada 11.4.1.3. Rest of North America 11.4.2. By Type Technique 11.4.3. By End-User 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Type Technique 11.5.3. By End-User 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 12.4.1. By Country 12.4.1.1. Brazil 12.4.1.2. Mexico 12.4.1.3. Rest of Latin America 12.4.2. By Type Technique 12.4.3. By End-User 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Type Technique 12.5.3. By End-User 13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 13.4.1. By Country 13.4.1.1. Germany13.4.1.2. France 13.4.1.2. United kingdom 13.4.1.3. Italy 13.4.1.4. Benelux 13.4.1.5. Nordic Countries 13.4.1.6. Rest of Europe 13.4.2. By Type Technique 13.4.3. By End-User 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Type Technique 13.5.3. By End-User 14. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 14.4.1. By Country 14.4.1.1. China 14.4.1.2. Japan 14.4.1.3. South Korea 14.4.1.4. Rest of Asia Pacific 14.4.2. By Type Technique 14.4.3. By End-User 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Type Technique 14.5.3. By End-User 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 15.4.1. By Country 15.4.1.1. GCC Countries 15.4.1.2. South Africa 15.4.1.3. Turkey 15.4.1.4. Rest of Middle East and Africa 15.4.2. By Type Technique 15.4.3. By End-User 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Type Technique 15.5.3. By End-User 16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. US Market Analysis 16.2.1. Value Proportion Analysis by Market Taxonomy 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.2.2.1. By Type Technique 16.2.2.2. By End-User 16.3. Canada Market Analysis 16.3.1. Value Proportion Analysis by Market Taxonomy 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.3.2.1. By Type Technique 16.3.2.2. By End-User 16.4. Mexico Market Analysis 16.4.1. Value Proportion Analysis by Market Taxonomy 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.4.2.1. By Type Technique 16.4.2.2. By End-User 16.5. Brazil Market Analysis 16.5.1. Value Proportion Analysis by Market Taxonomy 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.5.2.1. By Type Technique 16.5.2.2. By End-User 16.6. Germany Market Analysis 16.6.1. Value Proportion Analysis by Market Taxonomy 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.6.2.1. By Type Technique 16.6.2.2. By End-User 16.7. France Market Analysis 16.7.1. Value Proportion Analysis by Market Taxonomy 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.7.2.1. By Type Technique 16.7.2.2. By End-User 16.8. Italy Market Analysis 16.8.1. Value Proportion Analysis by Market Taxonomy 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.8.2.1. By Type Technique 16.8.2.2. By End-User 16.9. BENELUX Market Analysis 16.9.1. Value Proportion Analysis by Market Taxonomy 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.9.2.1. By Type Technique 16.9.2.2. By End-User 16.10. UK Market Analysis 16.10.1. Value Proportion Analysis by Market Taxonomy 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.10.2.1. By Type Technique 16.10.2.2. By End-User 16.11. Nordic Countries Market Analysis 16.11.1. Value Proportion Analysis by Market Taxonomy 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.11.2.1. By Type Technique 16.11.2.2. By End-User 16.12. China Market Analysis 16.12.1. Value Proportion Analysis by Market Taxonomy 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.12.2.1. By Type Technique 16.12.2.2. By End-User 16.13. Japan Market Analysis 16.13.1. Value Proportion Analysis by Market Taxonomy 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.13.2.1. By Type Technique 16.13.2.2. By End-User 16.14. South Korea Market Analysis 16.14.1. Value Proportion Analysis by Market Taxonomy 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.14.2.1. By Type Technique 16.14.2.2. By End-User 16.15. GCC Countries Market Analysis 16.15.1. Value Proportion Analysis by Market Taxonomy 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.15.2.1. By Type Technique 16.15.2.2. By End-User 16.16. South Africa Market Analysis 16.16.1. Value Proportion Analysis by Market Taxonomy 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.16.2.1. By Type Technique 16.16.2.2. By End-User 16.17. Turkey Market Analysis 16.17.1. Value Proportion Analysis by Market Taxonomy 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.17.2.1. By Type Technique 16.17.2.2. By End-User 16.17.3. Competition Landscape and Player Concentration in the Country 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration 17.3. Market Share Analysis of Top Players 17.4. Market Presence Analysis 17.4.1. By Regional footprint of Players 17.4.2. Product footprint by Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Competition Deep Dive 18.3.1. Medtronic 18.3.1.1. Overview 18.3.1.2. Product Portfolio 18.3.1.3. Sales Footprint 18.3.1.4. Strategy Overview 18.3.2. CooperSurgical Inc. 18.3.2.1. Overview 18.3.2.2. Product Portfolio 18.3.2.3. Sales Footprint 18.3.2.4. Strategy Overview 18.3.3. Boston Scientific Corp. 18.3.3.1. Overview 18.3.3.2. Product Portfolio 18.3.3.3. Sales Footprint 18.3.3.4. Strategy Overview 18.3.4. Ethicon Inc. (Johnson & Johnson) 18.3.4.1. Overview 18.3.4.2. Product Portfolio 18.3.4.3. Sales Footprint 18.3.4.4. Strategy Overview 18.3.5. Olympus Corp. 18.3.5.1. Overview 18.3.5.2. Product Portfolio 18.3.5.3. Sales Footprint 18.3.5.4. Strategy Overview 18.3.6. AngioDynamics 18.3.6.1. Overview 18.3.6.2. Product Portfolio 18.3.6.3. Sales Footprint 18.3.6.4. Strategy Overview 18.3.7. Hologic Inc. 18.3.7.1. Overview 18.3.7.2. Product Portfolio 18.3.7.3. Sales Footprint 18.3.7.4. Strategy Overview 18.3.8. Minerva Surgical 18.3.8.1. Overview 18.3.8.2. Product Portfolio 18.3.8.3. Sales Footprint 18.3.8.4. Strategy Overview 18.3.9. Richard Wolf GmbH 18.3.9.1. Overview 18.3.9.2. Product Portfolio 18.3.9.3. Sales Footprint 18.3.9.4. Strategy Overview 19. Assumptions and Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Endometrial Ablation Market
